当前位置:首页 - 行情中心 - 力诺药包(301188) - 财务分析 - 现金流量表

力诺药包

(301188)

  

流通市值:45.78亿  总市值:45.78亿
流通股本:2.39亿   总股本:2.39亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金375,946,773.32174,076,729.39825,930,185.97610,602,837.57
  收到其他与经营活动有关的现金56,609,317.676,616,478.3873,625,558.7313,142,547.03
  经营活动现金流入小计432,556,090.99180,693,207.77899,555,744.7623,745,384.6
  购买商品、接受劳务支付的现金289,572,407.81120,052,857.77497,242,985.1403,115,255.94
  支付给职工以及为职工支付的现金102,278,642.6246,441,474.96202,254,326.98142,111,523
  支付的各项税费19,418,443.627,485,484.7418,699,704.9816,190,919.46
  支付其他与经营活动有关的现金30,891,675.9722,011,664.4158,350,479.0231,131,855.53
  经营活动现金流出小计442,161,170.02195,991,481.88776,547,496.08592,549,553.93
  经营活动产生的现金流量净额-9,605,079.03-15,298,274.11123,008,248.6231,195,830.67
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,634,288.221,505,243.2310,757,449.529,235,128.51
  处置固定资产、无形资产和其他长期资产收回的现金净额8,836,140.8-442,866.27487,641
  收到的其他与投资活动有关的现金330,000,000309,886,3002,882,400,526.212,176,051,759.66
  投资活动现金流入小计340,470,429.02311,391,543.232,893,600,8422,185,774,529.17
  购建固定资产、无形资产和其他长期资产支付的现金88,068,576.7933,464,559.46209,555,723.42153,171,443.66
  支付其他与投资活动有关的现金230,300,00090,000,0002,752,233,281.581,823,443,600
  投资活动现金流出小计318,368,576.79123,464,559.462,961,789,0051,976,615,043.66
  投资活动产生的现金流量净额22,101,852.23187,926,983.77-68,188,163209,159,485.51
三、筹资活动产生的现金流量:
  取得借款收到的现金47,000,00027,000,00015,000,000-
  收到其他与筹资活动有关的现金6,500,0003,217,163.95-724,201.06
  筹资活动现金流入小计53,500,00030,217,163.9515,000,000724,201.06
  分配股利、利润或偿付利息支付的现金23,169,001.86138,449.9924,480,806.124,412,063.83
  支付其他与筹资活动有关的现金50,264,635.0118,753,449.1850,029,878.0450,029,952.95
  筹资活动现金流出小计73,433,636.8718,891,899.1774,510,684.1474,442,016.78
  筹资活动产生的现金流量净额-19,933,636.8711,325,264.78-59,510,684.14-73,717,815.72
四、汇率变动对现金及现金等价物的影响--2,097,602.35-
五、现金及现金等价物净增加额-7,436,863.67183,953,974.44-2,592,996.17166,637,500.46
  加:期初现金及现金等价物余额400,746,376.99403,339,373.16403,339,373.16403,339,373.16
  期末现金及现金等价物余额393,309,513.32587,293,347.6400,746,376.99569,976,873.62
补充资料:
  净利润40,967,465.56-66,067,595.87-
  资产减值准备4,532,820.54-11,067,217.36-
  固定资产和投资性房地产折旧56,191,084.12-104,250,095.73-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧56,191,084.12-104,250,095.73-
  无形资产摊销1,006,034.82-1,599,760.06-
  长期待摊费用摊销1,566,486.1-3,900,820.3-
  处置固定资产、无形资产和其他长期资产的损失-2,380,717.62--20,945.09-
  固定资产报废损失6,037.5-641,566.48-
  公允价值变动损失-1,105,578.17--1,454,305.47-
  财务费用13,152,143.83-23,458,754.53-
  投资损失-4,259,251.16--11,776,620.71-
  递延所得税-5,717,602.09--6,811,340.83-
  其中:递延所得税资产减少-3,465,303.76-3,021,715.38-
    递延所得税负债增加-2,252,298.33--9,833,056.21-
  存货的减少-78,084,712.51--77,534,046.37-
  经营性应收项目的减少-31,536,731.56--174,949,823.78-
  经营性应付项目的增加-4,196,435.25-184,569,520.54-
  现金的期末余额393,309,513.32-400,746,376.99-
  减:现金的期初余额400,746,376.99-403,339,373.16-
  现金及现金等价物的净增加额-7,436,863.67--2,592,996.17-
公告日期2025-08-212025-04-252025-04-252024-10-25
审计意见(境内)标准无保留意见
TOP↑